Full Text View
Tabular View
No Study Results Posted
Related Studies
Transition From Research to Disclosure in Human Genetics
This study is currently recruiting participants.
Verified by M.D. Anderson Cancer Center, September 2009
First Received: July 19, 2007   Last Updated: September 1, 2009   History of Changes
Sponsored by: M.D. Anderson Cancer Center
Information provided by: M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier: NCT00505466
  Purpose

The goal of this study is to design a means of providing research families, from diverse geographical locations, the chance to receive genetic testing after having been educated by video, and meetings or telephone conversations with a genetic counselor.


Condition Intervention
Education
Behavioral: Genetic Counseling

Study Type: Observational
Study Design: Case Control, Prospective
Official Title: Transition From Research to Disclosure in Human Genetics

Resource links provided by NLM:


Further study details as provided by M.D. Anderson Cancer Center:

Primary Outcome Measures:
  • Number of Participants Received Pre-test Genetic Counseling [ Time Frame: 10 Years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Number of participants completing genetic testing for p53 [ Time Frame: Baseline to time of follow-up (2 weeks, 6, and 12 months) ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

After receiving pre-test genetic counseling, participants will be given the opportunity to schedule a submission of a small sample of blood (about 6 tablespoons) for genetic testing for p53.


Estimated Enrollment: 371
Study Start Date: May 1999
Estimated Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Pre-Test Genetic Counseling + Genetic Sample Behavioral: Genetic Counseling
Genetic counseling conducted in person, by telephone with an M. D. Anderson Genetic Counselor, or with a local Genetic Counselor in conference with the M. D. Anderson Genetic Counselor.

Detailed Description:

Participants will receive pre-test genetic counseling in one of three ways: (1) in person at M. D. Anderson; (2) by telephone with an M. D. Anderson Genetic Counselor; (3) with a local Genetic Counselor in conference with the M. D. Anderson Genetic Counselor. After receiving pre-test genetic counseling, participants will be given the opportunity to schedule a submission of a small sample of blood (about 6 tablespoons) for genetic testing for p53.

Subjects who submit a sample will be required to see a genetic counselor to receive the results of the genetic test. Genetic counseling may take place at M. D. Anderson at no cost. Subjects may wish to have counseling close to their home, though they then are responsible for the cost of the counseling. If, after talking to the counselor, the participant wants to know the results of the test, he or she will be told. A participant will be given more counseling and advice on what other care might be needed and what other actions they should take.

Participants who decide to know the test results will schedule a telephone conversation with the genetic counselor within 2-3 months. This will include more counseling, with additional follow-up as needed.

Test results will be kept private. Names will not be used in computer records.

This is an investigational study. About 371 people will be offered genetic testing. This study is being performed only at M. D. Anderson.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Patient diagnosed with cancer or a participant with a family member who has had cancer.

Criteria

Inclusion Criteria:

  1. Members of families who have participated in the p53 project through Dr. Strong's lab are eligible. There are at least 73 kindreds including at least 371 participants living and who may be at risk of carrying a p53 germline mutation.
  2. The participants must provide informed consent.
  3. Be 18 years or older.
  4. Have the ability to speak, read and write English.

Exclusion:

N/A

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00505466

Contacts
Contact: Louise C. Strong, MD 713-792-7555

Locations
United States, Texas
U.T.M.D. Anderson Cancer Center Recruiting
Houston, Texas, United States, 77030
Principal Investigator: Louise C. Strong, MD            
Sponsors and Collaborators
M.D. Anderson Cancer Center
Investigators
Principal Investigator: Louise C. Strong, MD U.T.M.D. Anderson Cancer Center
  More Information

Additional Information:
No publications provided

Responsible Party: U.T.M.D. Anderson Cancer Center ( Louise C. Strong, MD/Professor )
Study ID Numbers: BS99-038
Study First Received: July 19, 2007
Last Updated: September 1, 2009
ClinicalTrials.gov Identifier: NCT00505466     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by M.D. Anderson Cancer Center:
Human Genetics
Genetic Counseling
Genetic Testing
p53 Mutation
Genetics

ClinicalTrials.gov processed this record on September 11, 2009